Cargando…

Rapid ex vivo reverse genetics identifies the essential determinants of prion protein toxicity

The cellular prion protein PrP(C) mediates the neurotoxicity of prions and other protein aggregates through poorly understood mechanisms. Antibody‐derived ligands against the globular domain of PrP(C) (GDL) can also initiate neurotoxicity by inducing an intramolecular R(208)‐H(140) hydrogen bond (“H...

Descripción completa

Detalles Bibliográficos
Autores principales: Reimann, Regina R., Puzio, Martina, Rosati, Antonella, Emmenegger, Marc, Schneider, Bernard L., Valdés, Pamela, Huang, Danzhi, Caflisch, Amedeo, Aguzzi, Adriano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10041163/
https://www.ncbi.nlm.nih.gov/pubmed/36329611
http://dx.doi.org/10.1111/bpa.13130
_version_ 1784912648122400768
author Reimann, Regina R.
Puzio, Martina
Rosati, Antonella
Emmenegger, Marc
Schneider, Bernard L.
Valdés, Pamela
Huang, Danzhi
Caflisch, Amedeo
Aguzzi, Adriano
author_facet Reimann, Regina R.
Puzio, Martina
Rosati, Antonella
Emmenegger, Marc
Schneider, Bernard L.
Valdés, Pamela
Huang, Danzhi
Caflisch, Amedeo
Aguzzi, Adriano
author_sort Reimann, Regina R.
collection PubMed
description The cellular prion protein PrP(C) mediates the neurotoxicity of prions and other protein aggregates through poorly understood mechanisms. Antibody‐derived ligands against the globular domain of PrP(C) (GDL) can also initiate neurotoxicity by inducing an intramolecular R(208)‐H(140) hydrogen bond (“H‐latch”) between the α2‐α3 and β2‐α2 loops of PrP(C). Importantly, GDL that suppresses the H‐latch prolong the life of prion‐infected mice, suggesting that GDL toxicity and prion infections exploit convergent pathways. To define the structural underpinnings of these phenomena, we transduced 19 individual PrP(C) variants to PrP(C)‐deficient cerebellar organotypic cultured slices using adenovirus‐associated viral vectors (AAV). We report that GDL toxicity requires a single N‐proximal cationic residue (K(27) or R(27)) within PrP(C). Alanine substitution of K(27) also prevented the toxicity of PrP(C) mutants that induce Shmerling syndrome, a neurodegenerative disease that is suppressed by co‐expression of wild‐type PrP(C). K(27) may represent an actionable target for compounds aimed at preventing prion‐related neurodegeneration.
format Online
Article
Text
id pubmed-10041163
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-100411632023-03-28 Rapid ex vivo reverse genetics identifies the essential determinants of prion protein toxicity Reimann, Regina R. Puzio, Martina Rosati, Antonella Emmenegger, Marc Schneider, Bernard L. Valdés, Pamela Huang, Danzhi Caflisch, Amedeo Aguzzi, Adriano Brain Pathol Research Articles The cellular prion protein PrP(C) mediates the neurotoxicity of prions and other protein aggregates through poorly understood mechanisms. Antibody‐derived ligands against the globular domain of PrP(C) (GDL) can also initiate neurotoxicity by inducing an intramolecular R(208)‐H(140) hydrogen bond (“H‐latch”) between the α2‐α3 and β2‐α2 loops of PrP(C). Importantly, GDL that suppresses the H‐latch prolong the life of prion‐infected mice, suggesting that GDL toxicity and prion infections exploit convergent pathways. To define the structural underpinnings of these phenomena, we transduced 19 individual PrP(C) variants to PrP(C)‐deficient cerebellar organotypic cultured slices using adenovirus‐associated viral vectors (AAV). We report that GDL toxicity requires a single N‐proximal cationic residue (K(27) or R(27)) within PrP(C). Alanine substitution of K(27) also prevented the toxicity of PrP(C) mutants that induce Shmerling syndrome, a neurodegenerative disease that is suppressed by co‐expression of wild‐type PrP(C). K(27) may represent an actionable target for compounds aimed at preventing prion‐related neurodegeneration. John Wiley and Sons Inc. 2022-11-03 /pmc/articles/PMC10041163/ /pubmed/36329611 http://dx.doi.org/10.1111/bpa.13130 Text en © 2022 The Authors. Brain Pathology published by John Wiley & Sons Ltd on behalf of International Society of Neuropathology. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Research Articles
Reimann, Regina R.
Puzio, Martina
Rosati, Antonella
Emmenegger, Marc
Schneider, Bernard L.
Valdés, Pamela
Huang, Danzhi
Caflisch, Amedeo
Aguzzi, Adriano
Rapid ex vivo reverse genetics identifies the essential determinants of prion protein toxicity
title Rapid ex vivo reverse genetics identifies the essential determinants of prion protein toxicity
title_full Rapid ex vivo reverse genetics identifies the essential determinants of prion protein toxicity
title_fullStr Rapid ex vivo reverse genetics identifies the essential determinants of prion protein toxicity
title_full_unstemmed Rapid ex vivo reverse genetics identifies the essential determinants of prion protein toxicity
title_short Rapid ex vivo reverse genetics identifies the essential determinants of prion protein toxicity
title_sort rapid ex vivo reverse genetics identifies the essential determinants of prion protein toxicity
topic Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10041163/
https://www.ncbi.nlm.nih.gov/pubmed/36329611
http://dx.doi.org/10.1111/bpa.13130
work_keys_str_mv AT reimannreginar rapidexvivoreversegeneticsidentifiestheessentialdeterminantsofprionproteintoxicity
AT puziomartina rapidexvivoreversegeneticsidentifiestheessentialdeterminantsofprionproteintoxicity
AT rosatiantonella rapidexvivoreversegeneticsidentifiestheessentialdeterminantsofprionproteintoxicity
AT emmeneggermarc rapidexvivoreversegeneticsidentifiestheessentialdeterminantsofprionproteintoxicity
AT schneiderbernardl rapidexvivoreversegeneticsidentifiestheessentialdeterminantsofprionproteintoxicity
AT valdespamela rapidexvivoreversegeneticsidentifiestheessentialdeterminantsofprionproteintoxicity
AT huangdanzhi rapidexvivoreversegeneticsidentifiestheessentialdeterminantsofprionproteintoxicity
AT caflischamedeo rapidexvivoreversegeneticsidentifiestheessentialdeterminantsofprionproteintoxicity
AT aguzziadriano rapidexvivoreversegeneticsidentifiestheessentialdeterminantsofprionproteintoxicity